Genfit SA (GNFT)
5.17
-0.75
(-12.67%)
USD |
NASDAQ |
May 31, 16:00
5.16
-0.01
(-0.19%)
After-Hours: 20:00
Genfit Cash and Short Term Investments (Quarterly): 85.99M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 85.99M |
| June 30, 2023 | 121.53M |
| December 31, 2022 | 150.73M |
| June 30, 2022 | 218.44M |
| December 31, 2021 | 292.97M |
| June 30, 2021 | 124.21M |
| December 31, 2020 | 210.36M |
| June 30, 2020 | 253.86M |
| December 31, 2019 | 310.00M |
| June 30, 2019 | 320.54M |
| December 31, 2018 | 237.06M |
| June 30, 2018 | 275.19M |
| June 30, 2018 | 275.19M |
| December 31, 2017 | 328.50M |
| June 30, 2017 | 144.46M |
| June 30, 2017 | 144.46M |
| December 31, 2016 | 160.98M |
| June 30, 2016 | 105.27M |
| June 30, 2016 | 105.27M |
| Date | Value |
|---|---|
| December 31, 2015 | 65.72M |
| June 30, 2015 | 73.25M |
| June 30, 2015 | 73.25M |
| December 31, 2014 | 92.42M |
| June 30, 2014 | 90.01M |
| June 30, 2014 | 90.01M |
| December 31, 2013 | 28.89M |
| June 30, 2013 | 38.26M |
| June 30, 2013 | 38.26M |
| December 31, 2012 | 8.337M |
| June 30, 2012 | 13.76M |
| June 30, 2012 | 13.76M |
| December 31, 2011 | 16.59M |
| June 30, 2011 | 14.75M |
| June 30, 2011 | 14.75M |
| December 31, 2010 | 18.54M |
| June 30, 2010 | 22.02M |
| December 31, 2009 | 24.93M |
| June 30, 2009 | 29.00M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
85.99M
Minimum
Dec 2023
320.54M
Maximum
Jun 2019
208.86M
Average
214.40M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| DBV Technologies SA | 101.52M |
| Cellectis SA | 149.17M |
| Biophytis SA | 6.560M |
| Edap TMS SA | 41.51M |
| Adaptimmune Therapeutics PLC | 143.65M |